Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 8Rectal Neoplasms 4Anus Neoplasms 4Urinary Bladder Neoplasms 3Pancreatic Adenocarcinoma 3Ovarian Neoplasms 2Klatskin Tumor 2Gallbladder Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Cholangiocarcinoma 2Anal Canal Carcinoma 2Adenocarcinoma Of Esophagus 2Urethral Neoplasms 1Ureteral Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Somatostatinoma 1Sinonasal undifferentiated carcinoma 1Paranasal Sinus Neoplasms 1Neoplasm Metastasis 1Metastatic Small Intestinal Adenocarcinoma 1Lung Neoplasms 1Keratosis, Actinic 1HIV Infections 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1Clinical Stage 0 Gastric Cancer AJCC v8 1

Interventions

dehydroftorafur 1Taxes 1Ramucirumab 1Paclitaxel 1Leucovorin 1Irinotecan 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Metastatic Small Intestinal Adenocarcinoma × dehydroftorafur × Clear all
NCT04205968 2025-11-05

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

SWOG Cancer Research Network

Phase 2 Recruiting
94 enrolled

Metastatic Small Intestinal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡